NYSE:NSPR

Inspiremd Stock News

Healthcare > Medical - Devices

Buy NSPR

*Your capital is at risk

$0.96

-0.0499 (-4.94%)

At Close: Jun 03, 2026

28 Stocks Moving In Thursday's Pre-Market Session

12:00am, Thursday, 11'th Apr 2019

Empery Asset Management Reports 7.36% Passive Stake In InspireMD

12:00am, Wednesday, 10'th Apr 2019

Sabby Announces 7.85% Passive Stake In Inspire MD

12:00am, Monday, 08'th Apr 2019

52 Biggest Movers From Yesterday

12:00am, Friday, 05'th Apr 2019

Mid-Afternoon Market Update: Dow Up 135 Points; Recro Pharma Shares Spike Higher

12:00am, Thursday, 04'th Apr 2019

InspireMD Reports Offering Of Common Stock, No Size Disclosed

12:00am, Wednesday, 03'rd Apr 2019

InspireMD Reports 1-For-50 Reverse Stock Split, Effective Mar. 29, 2019

12:00am, Tuesday, 26'th Mar 2019

InspireMD Q4 EPS $(0.05) Up From $(7.38) YoY, Sales $822K Down From $833K YoY

12:00am, Tuesday, 19'th Feb 2019

The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings

12:00am, Friday, 15'th Feb 2019

UPDATE: InspireMD Says 'CGuard™ EPS shows encouraging interim results verses a conventional carotid stent in absence of any adverse clinical events in the CGuard™ arm'

12:00am, Thursday, 24'th Jan 2019

InspireMD shares are trading higher after the company announced two successful live clinical clinical case transmissions featuring CGuard EPS.

12:00am, Wednesday, 23'rd Jan 2019

InspireMD Announces Results From Initial Clinical Study Of CGuard Embolic Prevention System (EPS) With SmartFit Technology

12:00am, Tuesday, 22'nd Jan 2019

InspireMD Announced That Its Cguard Carotid Embolic Prevention System Will Be Featured In Two Live Case Transmissions At The Leipzig Interventional Course 2019 To Be Held From January 22-25 At The Trade Fair Leipzig, Hall 2 In Leipzig, Germany

Inspiremd Stock News

28 Stocks Moving In Thursday's Pre-Market Session

Empery Asset Management Reports 7.36% Passive Stake In InspireMD

Sabby Announces 7.85% Passive Stake In Inspire MD

52 Biggest Movers From Yesterday

Mid-Afternoon Market Update: Dow Up 135 Points; Recro Pharma Shares Spike Higher

InspireMD Reports Offering Of Common Stock, No Size Disclosed

InspireMD Reports 1-For-50 Reverse Stock Split, Effective Mar. 29, 2019

InspireMD Q4 EPS $(0.05) Up From $(7.38) YoY, Sales $822K Down From $833K YoY

The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings

UPDATE: InspireMD Says 'CGuard™ EPS shows encouraging interim results verses a conventional carotid stent in absence of any adverse clinical events in the CGuard™ arm'

InspireMD shares are trading higher after the company announced two successful live clinical clinical case transmissions featuring CGuard EPS.

InspireMD Announces Results From Initial Clinical Study Of CGuard Embolic Prevention System (EPS) With SmartFit Technology

InspireMD Announced That Its Cguard Carotid Embolic Prevention System Will Be Featured In Two Live Case Transmissions At The Leipzig Interventional Course 2019 To Be Held From January 22-25 At The Trade Fair Leipzig, Hall 2 In Leipzig, Germany

InspireMD distributes CGuard system in South Africa

InspireMD Reports Received Noncompliance Notice From NYSE American

Top Fintech Company